Retail sale of pharmaceutical products
NORSUND GRUPPEN AS
Revenue 2024
NOK 641,000
Operating profit
NOK −524,000
Equity
NOK 78.0m
Incorporated
2017
Share capital
NOK 200,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 641k | |
| Total operating costs | 1.2m | |
| Operating profit (EBIT) | −524k | |
| Net financial items | 32.9m | |
| Profit for the year | 25.5m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 155.6m | |
| of which current assets | 4.2m | |
| Equity | 78.0m | |
| Total liabilities | 77.5m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.